Cargando…

Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis

Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. Deregulated DNA methylation landscapes are ubiquitous in human cancers. Interpretation of epigenetic aberrations in HCC is confounded by multiple etiologic drivers and underlying cirrhosis. We globally profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Hlady, Ryan A., Tiedemann, Rochelle L., Puszyk, William, Zendejas, Ivan, Roberts, Lewis R., Choi, Jeong-Hyeon, Liu, Chen, Robertson, Keith D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253444/
https://www.ncbi.nlm.nih.gov/pubmed/25294808
_version_ 1782347259481948160
author Hlady, Ryan A.
Tiedemann, Rochelle L.
Puszyk, William
Zendejas, Ivan
Roberts, Lewis R.
Choi, Jeong-Hyeon
Liu, Chen
Robertson, Keith D.
author_facet Hlady, Ryan A.
Tiedemann, Rochelle L.
Puszyk, William
Zendejas, Ivan
Roberts, Lewis R.
Choi, Jeong-Hyeon
Liu, Chen
Robertson, Keith D.
author_sort Hlady, Ryan A.
collection PubMed
description Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. Deregulated DNA methylation landscapes are ubiquitous in human cancers. Interpretation of epigenetic aberrations in HCC is confounded by multiple etiologic drivers and underlying cirrhosis. We globally profiled the DNA methylome of 34 normal and 122 liver disease tissues arising in settings of hepatitis B (HBV) or C (HCV) viral infection, alcoholism (EtOH), and other causes to examine how these environmental agents impact DNA methylation in a manner that contributes to liver disease. Our results demonstrate that each ‘exposure’ leaves unique and overlapping signatures on the methylome. CpGs aberrantly methylated in cirrhosis-HCV and conserved in HCC were enriched for cancer driver genes, suggesting a pathogenic role for HCV-induced methylation changes. Additionally, large genomic regions displaying stepwise hypermethylation or hypomethylation during disease progression were identified. HCC-HCV/EtOH methylomes overlap highly with cryptogenic HCC, suggesting shared epigenetically deregulated pathways for hepatocarcinogenesis. Finally, overlapping methylation abnormalities between primary and cultured tumors unveil conserved epigenetic signatures in HCC. Taken together, this study reveals profound epigenome deregulation in HCC beginning during cirrhosis and influenced by common environmental agents. These results lay the foundation for defining epigenetic drivers and clinically useful methylation markers for HCC.
format Online
Article
Text
id pubmed-4253444
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-42534442014-12-03 Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis Hlady, Ryan A. Tiedemann, Rochelle L. Puszyk, William Zendejas, Ivan Roberts, Lewis R. Choi, Jeong-Hyeon Liu, Chen Robertson, Keith D. Oncotarget Research Paper Hepatocellular carcinoma (HCC) is the second most common cause of cancer deaths worldwide. Deregulated DNA methylation landscapes are ubiquitous in human cancers. Interpretation of epigenetic aberrations in HCC is confounded by multiple etiologic drivers and underlying cirrhosis. We globally profiled the DNA methylome of 34 normal and 122 liver disease tissues arising in settings of hepatitis B (HBV) or C (HCV) viral infection, alcoholism (EtOH), and other causes to examine how these environmental agents impact DNA methylation in a manner that contributes to liver disease. Our results demonstrate that each ‘exposure’ leaves unique and overlapping signatures on the methylome. CpGs aberrantly methylated in cirrhosis-HCV and conserved in HCC were enriched for cancer driver genes, suggesting a pathogenic role for HCV-induced methylation changes. Additionally, large genomic regions displaying stepwise hypermethylation or hypomethylation during disease progression were identified. HCC-HCV/EtOH methylomes overlap highly with cryptogenic HCC, suggesting shared epigenetically deregulated pathways for hepatocarcinogenesis. Finally, overlapping methylation abnormalities between primary and cultured tumors unveil conserved epigenetic signatures in HCC. Taken together, this study reveals profound epigenome deregulation in HCC beginning during cirrhosis and influenced by common environmental agents. These results lay the foundation for defining epigenetic drivers and clinically useful methylation markers for HCC. Impact Journals LLC 2014-09-08 /pmc/articles/PMC4253444/ /pubmed/25294808 Text en Copyright: © 2014 Hlady et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Hlady, Ryan A.
Tiedemann, Rochelle L.
Puszyk, William
Zendejas, Ivan
Roberts, Lewis R.
Choi, Jeong-Hyeon
Liu, Chen
Robertson, Keith D.
Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis
title Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis
title_full Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis
title_fullStr Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis
title_full_unstemmed Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis
title_short Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis
title_sort epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253444/
https://www.ncbi.nlm.nih.gov/pubmed/25294808
work_keys_str_mv AT hladyryana epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis
AT tiedemannrochellel epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis
AT puszykwilliam epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis
AT zendejasivan epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis
AT robertslewisr epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis
AT choijeonghyeon epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis
AT liuchen epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis
AT robertsonkeithd epigeneticsignaturesofalcoholabuseandhepatitisinfectionduringhumanhepatocarcinogenesis